Medline MDLN
NASDAQ MDLN
$34.05 -0.64 (-1.84%)
As of: Sep 9, 2026 · 3:59 PM EDT

Medline (MDLN) Gross Margin (2025 - 2026)

Medline's (MDLN) quarterly Gross Margin came in at 28.82% in Q2 2026, up 116.0% year-over-year from 13.34% in Q2 2025, and up 15.1% quarter-over-quarter from 25.04% in Q1 2026.

Analysis

Medline (MDLN) Gross Margin (2025 - 2026) Analysis & Trends

Medline (MDLN) has reported Gross Margin for 2 consecutive years, with 28.82% the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Gross Margin rose 116.0% year-over-year to 28.82% in Q2 2026; TTM through Jun 2026 was 27.25%, a N/A change from a year earlier, with the FY2025 full-year figure at 26.44%, down 91.0% from the prior year.
  • Gross Margin was 28.82% for Q2 2026 at Medline, up from 25.04% in the prior quarter.
  • Over five years, Gross Margin peaked at 28.82% in Q2 2026 and troughed at 25.04% in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Becton Dickinson 50.32 Bn 49.46 Bn 2.32 Bn 46.46%
2 Medline 48.11 Bn 52.93 Bn 2.22 Bn 28.82%
3 West Pharmaceutical Services 23.93 Bn 23.49 Bn 329.20 Mn 37.74%
4 Baxter International 13.34 Bn 11.16 Bn 1.03 Bn 34.86%
5 Stevanato Group S.p.A 6.21 Bn 6.11 Bn 100.91 Mn 28.75%
6 Acme United 241.34 Mn 236.30 Mn 26.69 Mn 42.55%
7 Rockwell Medical 31.74 Mn 6.94 Mn 3.24 Mn 18.24%
8 Retractable Technologies 21.26 Mn -18.61 Mn 190,852.00 2.65%
9 United Health Products 12.24 Mn 12.21 Mn - -
10 Cuprina Holdings (Cayman) 8.09 Mn 4.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 28.82%
Mar 28, 2026 25.04%
Jun 28, 2025 27.66%
Mar 29, 2025 27.45%